Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers
- PMID:29246882
- PMCID: PMC5747598
- DOI: 10.2196/publichealth.7370
Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers
Abstract
Evidence documenting the global burden of disease from viral hepatitis was essential for the World Health Assembly to endorse the first Global Health Sector Strategy (GHSS) on viral hepatitis in May 2016. The GHSS on viral hepatitis proposes to eliminate viral hepatitis as a public health threat by 2030. The GHSS on viral hepatitis is in line with targets for HIV infection and tuberculosis as part of the Sustainable Development Goals. As coordination between hepatitis and HIV programs aims to optimize the use of resources, guidance is also needed to align the strategic information components of the 2 programs. The World Health Organization monitoring and evaluation framework for viral hepatitis B and C follows an approach similar to the one of HIV, including components on the following: (1) context (prevalence of infection), (2) input, (3) output and outcome, including the cascade of prevention and treatment, and (4) impact (incidence and mortality). Data systems that are needed to inform this framework include (1) surveillance for acute hepatitis, chronic infections, and sequelae and (2) program data documenting prevention and treatment, which for the latter includes a database of patients. Overall, the commonalities between HIV and hepatitis at the strategic, policy, technical, and implementation levels justify coordination, strategic linkage, or integration, depending on the type of HIV and viral hepatitis epidemics. Strategic information is a critical area of this alignment under the principle of what gets measured gets done. It is facilitated because the monitoring and evaluation frameworks for HIV and viral hepatitis were constructed using a similar approach. However, for areas where elimination of viral hepatitis requires data that cannot be collected through the HIV program, collaborations are needed with immunization, communicable disease control, tuberculosis, and hepatology centers to ensure collection of information for the remaining indicators.
Keywords: HIV; evaluation; hepatitis; surveillance.
©Yvan Hutin, Daniel Low-Beer, Isabel Bergeri, Sarah Hess, Jesus Maria Garcia-Calleja, Chika Hayashi, Antons Mozalevskis, Annemarie Rinder Stengaard, Keith Sabin, Hande Harmanci, Marc Bulterys. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 15.12.2017.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
- Tuberculosis.Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.Bloom BR, et al.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.PMID:30212088Free Books & Documents.Review.
- Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.Shiferaw F, Letebo M, Bane A.Shiferaw F, et al.BMC Public Health. 2016 Aug 11;16(1):769. doi: 10.1186/s12889-016-3459-1.BMC Public Health. 2016.PMID:27514515Free PMC article.
- An Assessment of National Strategic Action Plans for Viral Hepatitis Elimination, 2016-2021.Njuguna HN, Hiebert L, Harris A, Morgan RL, Gupta N, Ward JW.Njuguna HN, et al.J Infect Dis. 2023 Sep 13;228(Suppl 3):S148-S153. doi: 10.1093/infdis/jiad346.J Infect Dis. 2023.PMID:37703342
- [Introduction of World Health Organization Strategies and the Technical Advisory Committee actions on viral hepatitis control and status of the elimination of viral hepatitis in China].Cui FQ, Wang FZ, Zheng H, Liang XF.Cui FQ, et al.Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Sep 10;42(9):1523-1526. doi: 10.3760/cma.j.cn112338-20210319-00225.Zhonghua Liu Xing Bing Xue Za Zhi. 2021.PMID:34814578Chinese.
- Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination.Vo Quang E, Shimakawa Y, Nahon P.Vo Quang E, et al.Liver Int. 2021 May;41(5):915-927. doi: 10.1111/liv.14843. Epub 2021 Mar 18.Liver Int. 2021.PMID:33641230Review.
Cited by
- Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, de Martel C.Alberts CJ, et al.Lancet Gastroenterol Hepatol. 2022 Aug;7(8):724-735. doi: 10.1016/S2468-1253(22)00050-4. Epub 2022 May 14.Lancet Gastroenterol Hepatol. 2022.PMID:35576953Free PMC article.
- The hepatitis C virus in Iran: health policy, historical, ethical issues and future challenges.Behzadifar M, Azari S, Gorji HA, Martini M, Bragazzi NL.Behzadifar M, et al.J Prev Med Hyg. 2020 Apr 2;61(1):E109-E118. doi: 10.15167/2421-4248/jpmh2020.61.1.1438. eCollection 2020 Mar.J Prev Med Hyg. 2020.PMID:32490276Free PMC article.
- Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.Duffell E, Cortez-Pinto H, Simonova M, Dalgard O, Dahl EH, de Martel C, Mozalevskis A, Buti M, Pavlova S, Hadzhilova T, Simões C, Katzarov K, Mardh O.Duffell E, et al.J Viral Hepat. 2021 Aug;28(8):1177-1189. doi: 10.1111/jvh.13545. Epub 2021 Jun 8.J Viral Hepat. 2021.PMID:34003542Free PMC article.
- Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017.Smith S, Harmanci H, Hutin Y, Hess S, Bulterys M, Peck R, Rewari B, Mozalevskis A, Shibeshi M, Mumba M, Le LV, Ishikawa N, Nolna D, Sereno L, Gore C, Goldberg DJ, Hutchinson S.Smith S, et al.JHEP Rep. 2019 May 10;1(2):81-89. doi: 10.1016/j.jhepr.2019.04.002. eCollection 2019 Aug.JHEP Rep. 2019.PMID:32039355Free PMC article.
- Know Your Epidemic, Strengthen Your Response: Developing a New HIV Surveillance Architecture to Guide HIV Resource Allocation and Target Decisions.Rice B, Sanchez T, Baral S, Mee P, Sabin K, Garcia-Calleja JM, Hargreaves J.Rice B, et al.JMIR Public Health Surveill. 2018 Feb 14;4(1):e18. doi: 10.2196/publichealth.9386.JMIR Public Health Surveill. 2018.PMID:29444766Free PMC article.
References
- World Health Organization. 2017. Apr, Global hepatitis report, 2017http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/6uVoLg3IA
- GBD 2013 Mortality and Causes of Death Collaborators Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117–171. doi: 10.1016/S0140-6736(14)61682-2.http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61682-... - DOI - PMC - PubMed
- World Health Organization. 2016. Jun, Global health sector strategy on viral hepatitis, 2016-2021http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pd...6um8mCBhx.
- World Health Organization. 2016. Global health sector strategy on HIV, 2016-2021http://apps.who.int/iris/bitstream/10665/246178/1/WHO-HIV-2016.05-eng.pd...6um8soxXT.
- World Health Organization. Global health sector strategy on sexually transmitted infections, 2016-2021http://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/6um92tqlT
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials